168 related articles for article (PubMed ID: 38582956)
1. CD74 as a prognostic and M1 macrophage infiltration marker in a comprehensive pan-cancer analysis.
Li RQ; Yan L; Zhang L; Zhao Y; Lian J
Sci Rep; 2024 Apr; 14(1):8125. PubMed ID: 38582956
[TBL] [Abstract][Full Text] [Related]
2. JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer.
Liang X; Zhang H; Wang Z; Zhang X; Dai Z; Zhang J; Luo P; Zhang L; Hu J; Liu Z; Bi C; Cheng Q
Front Immunol; 2022; 13():875786. PubMed ID: 35898493
[TBL] [Abstract][Full Text] [Related]
3. Targetted inhibition of CD74 attenuates adipose COX-2-MIF-mediated M1 macrophage polarization and retards obesity-related adipose tissue inflammation and insulin resistance.
Chan PC; Wu TN; Chen YC; Lu CH; Wabitsch M; Tian YF; Hsieh PS
Clin Sci (Lond); 2018 Jul; 132(14):1581-1596. PubMed ID: 29773671
[TBL] [Abstract][Full Text] [Related]
4. PSME2 offers value as a biomarker of M1 macrophage infiltration in pan-cancer and inhibits osteosarcoma malignant phenotypes.
Li R; Yan L; Jiu J; Liu H; Li D; Li X; Zhang J; Li S; Fan Z; Lv Z; Zhu Y; Wang B
Int J Biol Sci; 2024; 20(4):1452-1470. PubMed ID: 38385075
[TBL] [Abstract][Full Text] [Related]
5. CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas.
Xu S; Li X; Tang L; Liu Z; Yang K; Cheng Q
Front Mol Biosci; 2021; 8():706949. PubMed ID: 34540893
[No Abstract] [Full Text] [Related]
6. Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma.
Huang X; Tan J; Chen M; Zheng W; Zou S; Ye X; Li Y; Wu M
Biomolecules; 2023 May; 13(6):. PubMed ID: 37371463
[TBL] [Abstract][Full Text] [Related]
7. MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas.
Zeiner PS; Preusse C; Blank AE; Zachskorn C; Baumgarten P; Caspary L; Braczynski AK; Weissenberger J; Bratzke H; Reiß S; Pennartz S; Winkelmann R; Senft C; Plate KH; Wischhusen J; Stenzel W; Harter PN; Mittelbronn M
Brain Pathol; 2015 Jul; 25(4):491-504. PubMed ID: 25175718
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker.
Chen W; Zou F; Song T; Xia Y; Xing J; Rao T; Zhou X; Ning J; Zhao S; Yu W; Cheng F
Aging (Albany NY); 2023 Oct; 15(21):11891-11917. PubMed ID: 37905956
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
10. Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.
Ma P; Sun W
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14597-14617. PubMed ID: 37580402
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
12. Effect of CD74 on the prognosis of patients with resectable pancreatic cancer.
Zhang JF; Hua R; Liu DJ; Liu W; Huo YM; Sun YW
Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):81-6. PubMed ID: 24463084
[TBL] [Abstract][Full Text] [Related]
13. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
14. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
[TBL] [Abstract][Full Text] [Related]
15. Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.
Cheng RJ; Deng WG; Niu CB; Li YY; Fu Y
Int J Gynecol Cancer; 2011 Aug; 21(6):1004-12. PubMed ID: 21792010
[TBL] [Abstract][Full Text] [Related]
16. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
17. Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.
Figueiredo CR; Azevedo RA; Mousdell S; Resende-Lara PT; Ireland L; Santos A; Girola N; Cunha RLOR; Schmid MC; Polonelli L; Travassos LR; Mielgo A
Front Immunol; 2018; 9():1132. PubMed ID: 29875777
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.
Zhu W; Wu J; Huang J; Xiao D; Li F; Wu C; Li X; Zeng H; Zheng J; Lai W; Wen X
Front Immunol; 2023; 14():1122670. PubMed ID: 37122696
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
20. HLA Class II Histocompatibility Antigen γ Chain (CD74) Expression Is Associated with Immune Cell Infiltration and Favorable Outcome in Breast Cancer.
Noer JB; Talman MM; Moreira JMA
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
